Cited by 211Menstrual Health and DisordersMaternal Mental Health During Pregnancy and PostpartumMenopause: Health Impacts and Treatments

ISPMD consensus on the management of premenstrual disorders

Open access
Consensus Group of the International Society for Premenstrual Disorders, Nevatte, Tracy, O’Brien, Patrick Michael Shaughn, Bäckström, Torbjorn, Brown, Candace, Dennerstein, Lorraine, Endicott, Jean, Epperson, C. Neill +14 more·2013·Archives of Women s Mental Health

Abstract

The second consensus meeting of the International Society for Premenstrual Disorders (ISPMD) took place in London during March 2011. The primary goal was to evaluate the published evidence and consider the expert opinions of the ISPMD members to reach a consensus on advice for the management of premenstrual disorders. Gynaecologists, psychiatrists, psychologists and pharmacologists each formally presented the evidence within their area of expertise; this was followed by an in-depth discussion leading to consensus recommendations. This article provides a comprehensive review of the outcomes from the meeting. The group discussed and agreed that careful diagnosis based on the recommendations and classification derived from the first ISPMD consensus conference is essential and should underlie the appropriate management strategy. Options for the management of premenstrual disorders fall under two broad categories, (a) those influencing central nervous activity, particularly the modulation of the neurotransmitter serotonin and (b) those that suppress ovulation. Psychotropic medication, such as selective serotonin reuptake inhibitors, probably acts by dampening the influence of sex steroids on the brain. Oral contraceptives, gonadotropin-releasing hormone agonists, danazol and estradiol all most likely function by ovulation suppression. The role of oophorectomy was also considered in this respect. Alternative therapies are also addressed, with, e.g. cognitive behavioural therapy, calcium supplements and Vitex agnus castus warranting further exploration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00737-013-0346-y

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pre-intervention, the majority of women reported feeling angry, irritable and oversensitive.

    “Pre-intervention, the majority of women reported feeling angry, irritable and oversensitive, which is central to clinical definitions of PMDs [3], and has been reported in previous qualitative PMDs research [7, 76, 77].”

    From Evaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait list control: A randomized controlled trial (2017) · cites this paper as [3]

    Citation [3] is attached to the assertion that feeling angry, irritable and oversensitive is central to clinical definitions of PMDs, not to the citing study’s pre-intervention finding. The paper’s Introduction > Classification says that timing, rather than the nature of symptoms, is important for classifying core PMDs. Its Epidemiology section identifies irritability as a prevalent mood symptom, but that does not make the listed feelings central to the definition. (LLM, conf=0.82)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Consensus Group of the International Society for Premenstrual Disorders, Nevatte, T., O’Brien, P. M. S., Bäckström, T., Brown, C., Dennerstein, L., Endicott, J., Epperson, C. N., Eriksson, E., Freeman, E. W., Halbreich, U., Ismail, K., Panay, N., Pearlstein, T., Rapkin, A., Reid, R., Rubinow, D., Schmidt, P., Steiner, M., Studd, J., Sundström-Poromaa, I., & Yonkers, K.
Affiliations
  • Keele University (GB)
  • Royal Stoke University Hospital (GB)
  • University of Tennessee Health Science Center (US)
  • The University of Melbourne (AU)
  • Columbia University (US)
  • University of Pennsylvania (US)
  • University at Buffalo, State University of New York (US)
  • Queen Charlotte's and Chelsea Hospital (GB)
  • Brown University (US)
  • University of California, Los Angeles (US)
  • University of North Carolina at Chapel Hill (US)
  • National Institute of Mental Health (US)
  • Chelsea and Westminster Hospital (GB)
  • Uppsala University (SE)
Corresponding author
Nevatte, Tracy
Venue
Archives of Women s Mental Health
Published
2013-04-27
Volume
16
Issue
4
Pages
279-291
ISSN
  • 1434-1816 (ISSN-L)
  • 1435-1102
OpenAlex
W2024556146
Cited by
211
References
111
Citations by year
2026: 8 · 2025: 13 · 2024: 16 · 2023: 21 · 2022: 16 · 2021: 17 · 2020: 45 · 2019: 16 · 2018: 5 · 2017: 19 · 2016: 10 · 2015: 14 · 2014: 10 · 2013: 1
FWCI
11.90
Type
journal article
Language
en
Open access
Locations
  • Archives of Women s Mental Health (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • National Institutes of Health
  • National Institute of Mental Health (ZIAMH002865)
  • National Institute on Drug Abuse (K24DA030301, R01DA018359)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
premenstrual disorders, premenstrual dysphoric disorder, premenstrual syndrome, management recommendations, serotonin modulation, selective serotonin reuptake inhibitors, ovulation inhibition, oral contraceptives, GnRH agonist, danazol, estradiol, oophorectomy, sex steroids, cognitive behavioral therapy, calcium supplementation, Vitex agnus-castus, complementary and alternative medicine, diagnosis and classification
MeSH terms
Female, Group Processes, Humans, Premenstrual Syndrome, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review